Punjab health authorities have ordered the recall of 10 batches of the medicine Lowplat Plus after laboratory testing found them to be substandard.
The Drug Testing Laboratory Punjab classified the affected batches as substandard following an impurities test, according to a notice issued by the Directorate of Drugs Control Punjab (DDCP).
The recalled medicine Lowplat Plus contains clopidogrel bisulphate 75mg and aspirin 75mg. The affected batches have expiry dates in January and February 2028.
The batches listed in the recall are 6B300, 6B301, 6B268, 6B277 with an expiry date of Jan 2028, and batch Numbers 6C135, 6C136, 6C137, 6C138, 6C129 and 6C270 with an expiry date of February 2028.
Authorities have instructed pharmacies, wholesalers, distributors and healthcare facilities to immediately stop dispensing the affected batches and report their remaining stocks and consumption records.
The manufacturer and market authorization holder have also been directed to initiate an immediate recall, provide complete distribution records, and conduct an investigation into the cause of the quality failure.
Patients and consumers have been advised to stop using the affected batches immediately, with the notice warning that they may pose a health risk.
The Directorate of Drugs Control Punjab has also asked healthcare professionals to report any adverse effects associated with the recalled batches through the provincial pharmacovigilance system.
